
Even though macroeconomic challenges plagued the overall economy, pharmaceutical firms have fared well because of the solid demand for their products. Given the resilience, investing in quality pharmaceutical stocks Astellas Pharma Inc. (ALPMY), Ono Pharmaceutical Co., Ltd. (OPHLY), and Santen Pharmaceutical Co., Ltd. (SNPHY) could be wise, which are currently trading under $15.
Last month, despite the meltdown in the banking sector, the Federal Reserve raised interest rates by a quarter point, in line with market expectations. This raised the lending rates to a range of 4.75% to 5%, marking the highest level since September 2007.